Investor List:

Top Therapeutics Seed Investors in Boston / New England (42)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Manufacturing (Series B), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Wasim Malik, Managing Partner at Iaso Ventures
Wasim Malik
Iaso Ventures·Managing Partner
Sweet spot: $500K
Range: $100K - $2.5M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in AI (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in AI (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Impact (Seed), Investors in Impact (Series A), Investors in Impact (Seed), Investors in Impact (Series A), Investors in Impact (Pre-seed), Investors in Impact (Pre-seed)
Photo of Jorge Cortell, General Partner at Unveil Pharma
Jorge Cortell
Unveil Pharma·General Partner
Sweet spot: $1.5M
Range: $500K - $20.0M
Investors in Cambridge (MA), Investors in Boston (MA), Investors in Singapore
Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who were founders (Other Lists), Investors in BioTech (Series A), Investors in Diverse Investors (Other Lists), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Series A), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Drug Delivery (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Drug Delivery (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Pre-seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series A), Investors in Drug Delivery (Pre-seed), Investors in Health IT (Seed), Investors in Medical Devices (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed)
Photo of Miri Polachek, Venture Partner at quadraScope Venture Fund
Miri Polachek
quadraScope Venture Fund·Venture Partner
Sweet spot: $300K
Range: $100K - $1M
Investors in SF Bay Area (CA), Investors in Boston / New England, Investors in United States, Investors in Israel
Photo of Wes Schifone, Scout at CRV
Wes Schifone
CRV·Scout
Sweet spot: $50K
Range: $25K - $100K
Investors in Boston (MA)
Investors in Web3/Blockchain (Series B), Investors in Consumer Health (Series B), Investors in Web3/Crypto (Series B), Investors in Consumer Health (Series A), Investors in Web3/Blockchain (Seed), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Seed), Investors in Web3/Crypto (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Seed), Investors in Consumer Health (Seed), Investors in Web3/Crypto (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Series A), Investors in Web3/Crypto (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Web3/Blockchain (Series B), Investors in Consumer Health (Series B), Investors in Web3/Crypto (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series B), Investors in Digital Health (Series B), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Mansoor Alam, Angel at Independent
Mansoor Alam
Sweet spot: $50K
Range: $25K - $200K
Investors in Boston (MA), Investors in Palo Alto (CA)
Investors in Consumer Health (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Creator/Passion Economy (Seed), Investors in Creator/Passion Economy (Seed), Investors in Creator/Passion Economy (Seed), Investors in Diagnostics (Pre-seed), Investors in Creator/Passion Economy (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Creator/Passion Economy (Pre-seed), Investors in Therapeutics (Seed), Investors in Digital Health (Pre-seed), Investors in Creator/Passion Economy (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Leyi Wang, Managing Director at 6 Dimensions Capital
Leyi Wang
6 Dimensions Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Lou Tartaglia, Managing Partner at Cure Ventures
Lou Tartaglia
Cure Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A)